Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study

By |2020-09-14T21:00:00+02:00September 14th, 2020|Categories: Coronavirus Nature|

Nature Medicine, Published online: 14 September 2020; doi:10.1038/s41591-020-1050-xA GMP-compliant process for generating human iPSC-derived mesenchymal stromal cells tested in a phase 1 trial is safe and well tolerated in subjects wit...

Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study

By |2020-09-14T22:00:00+02:00September 14th, 2020|Categories: Coronavirus Nature|

Nature Medicine, Published online: 14 September 2020; doi:10.1038/s41591-020-1050-xA GMP-compliant process for generating human iPSC-derived mesenchymal stromal cells tested in a phase 1 trial is safe and well tolerated in subjects wit...